Clinical and Molecular Characteristics of High-Risk, Recurrent, or Metastatic Endometrial Cancer That Is Human Epidermal Growth Factor Receptor 2-Low.
van Dijk D, Vermij L, León-Castillo A, Powell M, Jobsen J, Leary A, Bowes D, Mileshkin L, Genestie C, Jürgenliemk-Schulz I, de Kroon C, Post C, de Boer S, Nooij L, Kroep J, Creutzberg C, Smit V, Horeweg N, Bosse T, Westermann A.
van Dijk D, et al.
J Clin Oncol. 2024 Oct 7:JCO2302768. doi: 10.1200/JCO.23.02768. Online ahead of print.
J Clin Oncol. 2024.
PMID: 39374474